AIM
GSK icon

Alhambra Investment Management’s GSK GSK Stock Holding History

Alhambra Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-14,847
Closed -$607K – 173
2024
Q3 		$607K Buy
14,847
+1,366
+10% +$55.9K 0.31% 83
2024
Q2 		$519K Sell
13,481
-1,710
-11% -$71.9K 0.28% 89
2024
Q1 		$651K Sell
15,191
-229
-1% -$9.44K 0.36% 78
2023
Q4 		$571K Buy
15,420
+165
+1% +$5.92K 0.34% 82
2023
Q3 		$553K Buy
15,255
+432
+3% +$15.3K 0.36% 76
2023
Q2 		$528K Buy
+14,823
New +$532K 0.35% 79

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Alhambra Investment Management's GSK Position: Q4 2024 in Review

Alhambra Investment Management sold out of GSK (GSK) in Q4 2024, closing a stake of 14,847 shares — an estimated $607K sold.

Alhambra Investment Management first reported a position in GSK in Q2 2023 and held it in 6 quarters. The position peaked at $651K in Q1 2024. 848 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

  • Alhambra Investment Management reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
  • Alhambra Investment Management sold 14,847 GSK shares in Q4 2024, an estimated $607K.
  • Alhambra Investment Management first reported a position in GSK in Q2 2023 and held it in 6 quarters.
  • Alhambra Investment Management's GSK position peaked at $651K in Q1 2024.
  • 848 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on Alhambra Investment Management's 13F filing for Q4 2024, filed 15 Jan 2025.